BridgeMD
New treatment option for Lung Cancer (Diagnosis)
Official title Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
ClinicalTrials.gov ID: NCT07241182
What this study is testing
- What it's testing
- This randomized trial will test whether Antrodia cinnamomea supplement improves quality of life in lung cancer patients receiving platinum-based chemotherapy. Participants at Tri-Service General Hospital will be randomized to receive either Antrodia cinnamomea capsules or placebo for 3 months, with follow-up to 6 months (24 weeks).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Pathologically and radio-graphically diagnosed lung cancer
- Age greater than 18 years
- Received platinum-based chemotherapy
- Life expectancy of six months or longer
You likely can't join if
- Inability to comply with timely supplementation administration.
- Within 14 days prior to trial entry, laboratory data showing abnormal liver function, abnormal kidney function
- Within 30 days prior to trial entry, unexplained fever ≥38.5°C for 7 consecutive days or chronic diarrhea for 15 consecutive days.
- Currently receiving hormone therapy.
- Major cardiac disease or arrhythmia severe enough that the attending physician considers the patient unsuitable for trial participation.
- Major neuropathy.
See the full eligibility criteria
- Pathologically and radio-graphically diagnosed lung cancer
- Age greater than 18 years
- Received platinum-based chemotherapy
- Life expectancy of six months or longer
- Inability to comply with timely supplementation administration.
- Within 14 days prior to trial entry, laboratory data showing abnormal liver function, abnormal kidney function
- Within 30 days prior to trial entry, unexplained fever ≥38.5°C for 7 consecutive days or chronic diarrhea for 15 consecutive days.
- Currently receiving hormone therapy.
- Major cardiac disease or arrhythmia severe enough that the attending physician considers the patient unsuitable for trial participation.
- Major neuropathy.
- Patients with currently active acute infections.
- Patients with known allergies/allergic reactions to the investigational product or any components in their formulations.
- Patients currently taking supplements containing Antrodia camphorata extract.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.